{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:39:31Z","timestamp":1792636771633,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-026-02591-z","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:45:00Z","timestamp":1784915100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repeatability and replicability of the Respiratory Symptom Experience Scale (RSES): internal and external validation of smoking-status differences in respiratory symptoms"],"prefix":"10.1186","volume":"24","author":[{"given":"Pasquale","family":"Caponnetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Spicuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Caratozzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Belsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Nadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Anastasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Pluym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Polosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","volume":"389","author":"GBD 2015 Tobacco Collaborators","year":"2017","unstructured":"GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the global burden of disease study 2015. Lancet. 2017;389:1885\u2013906. https:\/\/doi.org\/10.1016\/S0140-6736(17)30819-X.","journal-title":"Lancet"},{"key":"2591_CR2","unstructured":"Tobacco. (2024). Tobacco. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco."},{"key":"2591_CR3","volume-title":"How Tobacco Smoke Causes Disease. The biology and behavioral basis for Smoking-Attributable disease: A report of the surgeon general","author":"U.S. Department of Health and Human Services","year":"2010","unstructured":"U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease. The biology and behavioral basis for Smoking-Attributable disease: A report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010."},{"issue":"9\u201310","key":"2591_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.drudis.2010.03.001","volume":"15","author":"JB Morjaria","year":"2010","unstructured":"Morjaria JB, Malerba M, Polosa R. Biologic and Pharmacologic therapies in clinical development for the inflammatory response in COPD. Drug Discov Today. 2010;15(9\u201310):396\u2013405.","journal-title":"Drug Discov Today"},{"issue":"11","key":"2591_CR5","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.jaip.2022.04.034","volume":"10","author":"NC Thomson","year":"2022","unstructured":"Thomson NC, Polosa R, Sin DD. Cigarette Smoking and Asthma. J Allergy Clin Immunol Pract. 2022;10(11):2783\u201397. https:\/\/doi.org\/10.1016\/j.jaip.2022.04.034.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"19","key":"2591_CR6","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","volume":"374","author":"PG Woodruff","year":"2016","unstructured":"Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, Gous- kova NA, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Lazarus SC, Martinez FJ, Paine R 3rd, Rennard S, Tashkin DP, Han MK, SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1505971.","journal-title":"N Engl J Med"},{"issue":"2","key":"2591_CR7","doi-asserted-by":"publisher","first-page":"00202","DOI":"10.1183\/23120541.00202-2022","volume":"8","author":"E Bazzan","year":"2022","unstructured":"Bazzan E, Semenzato U, Turato G, Biondini D, Cubero P, Marin-Oto M, Forner M, Tin\u00e8 M, Casara A, Baraldo S, Spagnolo P, Marin JM, Saetta M, Cosio MG. Symptomatic smokers without COPD have physiological changes heralding the development of COPD. ERJ Open Res. 2022;8(2):00202\u20132022. https:\/\/doi.org\/10.1183\/23120541.00202-2022.","journal-title":"ERJ Open Res"},{"issue":"5","key":"2591_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/jama.2023.11676","volume":"330","author":"W McKleroy","year":"2023","unstructured":"McKleroy W, Shing T, Anderson WH, Arjomandi M, Awan HA, Barjaktarevic I, Barr RG, Bleecker ER, Boscardin J, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Curtis JL, Dransfield M, Doerschuk CM, Dolezal BA, Drummond MB, Han MK, Hansel NN, Helton K, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Lazarus SC, Martinez FJ, Ohar J, Ortega VE, Paine R 3rd, Peters SP, Reinhardt JM, Rennard S, Smith BM, Tashkin DP, Couper D, Cooper CB, Woodruff PG. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry. JAMA. 2023;330(5):442\u201353. https:\/\/doi.org\/10.1001\/jama.2023.11676.","journal-title":"JAMA"},{"issue":"3","key":"2591_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1183\/09031936.04.00012704","volume":"23","author":"BW Willemse","year":"2004","unstructured":"Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3):464\u201376. https:\/\/doi.org\/10.1183\/09031936.04.00012704.","journal-title":"Eur Respir J"},{"issue":"21","key":"2591_CR10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1042\/CS20160268","volume":"130","author":"F Cibella","year":"2016","unstructured":"Cibella F, Campagna D, Caponnetto P, Amaradio MD, Caruso M, Russo C, Cockcroft DW, Polosa R. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clin Sci (Lond). 2016;130(21):1929\u201337. https:\/\/doi.org\/10.1042\/CS20160268. Epub 2016 Aug 19. PMID: 27543458.","journal-title":"Clin Sci (Lond)"},{"key":"2591_CR11","doi-asserted-by":"publisher","first-page":"e42628","DOI":"10.2196\/42628","volume":"9","author":"P Caponnetto","year":"2023","unstructured":"Caponnetto P, Campagna D, Benfatto M, Emma F, Caruso R, Caci M, Bus\u00e0 G, Pennisi B, Ceracchi A, Migliore M, Signorelli M. Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial. JMIR Public Health Surveill. 2023;9:e42628. https:\/\/doi.org\/10.2196\/42628.","journal-title":"JMIR Public Health Surveill"},{"key":"2591_CR12","unstructured":"United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: A report of the Surgeon General [Internet]. Washington (DC): US Department of Health and Human Services; 2020. PMID: 32255575."},{"key":"2591_CR13","doi-asserted-by":"publisher","unstructured":"Morjaria JB, Campagna D, Caci G, O'Leary R, Polosa R. Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence. Expert Rev Respir Med. 2022;16(11\u201312):1213\u20131226. https:\/\/doi.org\/10.1080\/17476348.2023.2167716.","DOI":"10.1080\/17476348.2023.2167716"},{"issue":"4","key":"2591_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/s0002-9343(99)00056-x","volume":"106","author":"RE Kanner","year":"1999","unstructured":"Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med. 1999;106(4):410\u20136. https:\/\/doi.org\/10.1016\/s0002-9343(99)00056-x.","journal-title":"Am J Med"},{"issue":"11","key":"2591_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.rmed.2011.04.016","volume":"105","author":"DP Tashkin","year":"2011","unstructured":"Tashkin DP, Rennard S, Taylor Hays J, Lawrence D, Marton JP, Lee TC. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med. 2011;105(11):1682\u201390. https:\/\/doi.org\/10.1016\/j.rmed.2011.04.016. Epub 2011 May 31. PMID: 21621992.","journal-title":"Respir Med"},{"key":"2591_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-1-13","volume":"1","author":"T van der Molen","year":"2003","unstructured":"van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13. https:\/\/doi.org\/10.1186\/1477-7525-1-13.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"2591_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648\u201354.","journal-title":"Eur Respir J"},{"issue":"2","key":"2591_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/2042098614524430","volume":"5","author":"KE Farsalinos","year":"2014","unstructured":"Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67\u201386. https:\/\/doi.org\/10.1177\/2042098614524430.","journal-title":"Ther Adv Drug Saf"},{"issue":"18","key":"2591_CR19","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2022.14847","volume":"328","author":"HD Dai","year":"2022","unstructured":"Dai HD, Leventhal AM, Khan AS. Trends in Urinary Biomarkers of Exposure to Nicotine and Carcinogens Among Adult e-Cigarette Vapers vs Cigarette Smokers in the US, 2013\u20132019. JAMA. 2022;328(18):1864\u20136. https:\/\/doi.org\/10.1001\/jama.2022.14847.","journal-title":"JAMA"},{"issue":"4","key":"2591_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/ntr\/ntad197","volume":"26","author":"S Shiffman","year":"2024","unstructured":"Shiffman S, Oliveri DR, Goldenson NI, Liang Q, Black RA, Mishra S. Comparing adult smokers who switched to JUUL versus continuing smokers: biomarkers of exposure and of potential harm and respiratory symptoms. Nicotine Tob Res. 2024;26(4):494\u2013502. https:\/\/doi.org\/10.1093\/ntr\/ntad197.","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"2591_CR21","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s11739-021-02837-2","volume":"16","author":"R Polosa","year":"2021","unstructured":"Polosa R. Examining the evidence for the health impact of combustion-free products: progress and prospects for tobacco harm reversal and reduction. Intern Emerg Med. 2021;16(8):2043\u20136. https:\/\/doi.org\/10.1007\/s11739-021-02837-2.","journal-title":"Intern Emerg Med"},{"key":"2591_CR22","doi-asserted-by":"publisher","first-page":"e44036","DOI":"10.2196\/44036","volume":"7","author":"S Shiffman","year":"2023","unstructured":"Shiffman S, McCaffrey SA, Hannon MJ, et al. A new questionnaire to assess respiratory symptoms (The respiratory symptom experience Scale): quantitative psychometric assessment and validation study. JMIR Form Res. 2023;7:e44036. https:\/\/doi.org\/10.2196\/44036.","journal-title":"JMIR Form Res"},{"key":"2591_CR23","volume-title":"Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science","author":"National Academies of","year":"2019","unstructured":"National Academies of. Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. Washington, DC: National Academies; 2019."},{"issue":"7604","key":"2591_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/533452a","volume":"533","author":"M Baker","year":"2016","unstructured":"Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533(7604):452\u20134. https:\/\/doi.org\/10.1038\/533452a.","journal-title":"Nature"},{"key":"2591_CR25","doi-asserted-by":"publisher","first-page":"Accept","DOI":"10.20517\/jeea.2025.69","volume":"4","author":"A Sajid","year":"2025","unstructured":"Sajid A, Pluym N, Burkhardt T, Belsey J, John I, Polosa R, Scherer M. Accurate verification of nicotine and tobacco product use or abstinence using a multi-biomarker approach. J Environ Expo Assess. 2025;4:Accept. https:\/\/doi.org\/10.20517\/jeea.2025.69.","journal-title":"J Environ Expo Assess"},{"key":"2591_CR26","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.crtox.2022.100067","volume":"3","author":"G Scherer","year":"2022","unstructured":"Scherer G, M\u00fctze J, Pluym N, Scherer M. Assessment of nicotine delivery and uptake in users of various tobacco\/nicotine products. Curr Res Toxicol. 2022;3:100067. https:\/\/doi.org\/10.1016\/j.crtox.2022.100067.","journal-title":"Curr Res Toxicol"},{"issue":"4","key":"2591_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1021\/acs.chemrestox.2c00020","volume":"35","author":"G Scherer","year":"2022","unstructured":"Scherer G, Scherer M, M\u00fctze J, Hauke T, Pluym N. Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco\/Nicotine Products. Chem Res Toxicol. 2022;35(4):684\u201393. https:\/\/doi.org\/10.1021\/acs.chemrestox.2c00020.","journal-title":"Chem Res Toxicol"},{"issue":"10","key":"2591_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/dta.3372","volume":"15","author":"G Scherer","year":"2023","unstructured":"Scherer G, Pluym N, Scherer M. Comparison of urinary mercapturic acid excretions in users of various tobacco\/nicotine products. Drug Test Anal. 2023;15(10):1107\u201326. https:\/\/doi.org\/10.1002\/dta.3372.","journal-title":"Drug Test Anal"},{"issue":"11","key":"2591_CR29","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1021\/acs.chemrestox.4c00258","volume":"37","author":"F Pilz","year":"2024","unstructured":"Pilz F, Burkhardt T, Scherer G, Scherer M, Pluym N. Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco\/nicotine Products by Nontargeted GC-MS\/MS Analysis. Chem Res Toxicol. 2024;37(11):1884\u2013902. https:\/\/doi.org\/10.1021\/acs.chemrestox.4c00258.","journal-title":"Chem Res Toxicol"},{"issue":"10","key":"2591_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/separations8100180","volume":"8","author":"T Burkhardt","year":"2021","unstructured":"Burkhardt T, Pluym N, Scherer G, Scherer M. 1,2-Propylene Glycol: A Biomarker of Exposure Specific to e-Cigarette Consumption. Separations. 2021;8(10):180. https:\/\/doi.org\/10.3390\/separations8100180.","journal-title":"Separations"},{"key":"2591_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.envres.2016.09.004","volume":"152","author":"M Maga","year":"2017","unstructured":"Maga M, Janik MK, Wachsmann A, Chrz\u0105stek-Janik O, Koziej M, Bajkowski M, Maga P, Tyrak K, W\u00f3jcik K, Gregorczyk-Maga I, Ni\u017cankowski R. Influence of air pollution on exhaled carbon monoxide levels in smokers and non-smokers. A prospective cross-sectional study. Environ Res. 2017;152:496\u2013502. https:\/\/doi.org\/10.1016\/j.envres.2016.09.004.","journal-title":"Environ Res"},{"issue":"1","key":"2591_CR32","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1186\/s12889-025-22824-y","volume":"25","author":"P Caponnetto","year":"2025","unstructured":"Caponnetto P, Shiffman S, Prezzavento GC, Polosa R. Assessing the Italian version of the respiratory symptom experience scale (IT-RSES) in smokers and former smokers: a validation study. BMC Public Health. 2025;25(1):1600. https:\/\/doi.org\/10.1186\/s12889-025-22824-y.","journal-title":"BMC Public Health"},{"key":"2591_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79. https:\/\/doi.org\/10.1186\/1477-7525-4-79.","journal-title":"Health Qual Life Outcomes"},{"key":"2591_CR34","unstructured":"https:\/\/ https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims."}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-026-02591-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-026-02591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-026-02591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:06:04Z","timestamp":1792634764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-026-02591-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1186\/s12955-026-02591-z","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was granted by the Health Research Authority (HRA) and Health and Care Research Wales (HCRW), the designated Institutional Review Board (IRB\/Ethics Committee) for this research (IRAS project ID: 322282; approval date: 14 March 2023). Written informed consent was obtained from all participants prior to enrolment.","order":1,"name":"Ethics","label":"Human ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}